SCHEMBL7096883

SCHEMBL7096883

Nc1cc2c(cc1Nc1c[c]ccc1)OCCO2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.37
KDM4E B2RXH2 5/20 0.37
GAA P10253 5/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
LMNA P02545 3/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
ALDH1A1 P00352 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
GFER P55789 1/20 0.32
MAPK14 Q16539 2/20 0.32
CASP1 P29466 1/20 0.32
NPC1 O15118 3/20 0.31
RAB9A P51151 3/20 0.31
PKM P14618 1/20 0.31
NFKB1 P19838 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7099283 0.91 MAPT (0.37) MAPTKDM4EGAASMN1; SMN2MEN1
SCHEMBL6427804 0.78 MAPT (0.44) MAPTGAASMN1; SMN2MEN1KMT2A
SCHEMBL28147013 0.76 GAA (0.41) MAPTKDM4EGAASMN1; SMN2MEN1
SCHEMBL27618345 0.72 MAPK14 (0.43) MAPTKDM4EGAASMN1; SMN2MEN1
SCHEMBL6383792 0.72 GAA (0.42) MAPTKDM4EGAASMN1; SMN2MEN1
SCHEMBL7100350 0.69 MAPT (0.43) MAPTKDM4EGAASMN1; SMN2MEN1
SCHEMBL7090460 0.68 HSD17B10 (0.43) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL1624046 0.68 NPC1 (0.39) MAPTKDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL6051227 0.68 AOC3 (0.39) MAPTKDM4EGAASMN1; SMN2MEN1
SCHEMBL6388023 0.67 GAA (0.35) MAPTKDM4EGAASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326606-A2 EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS PFIZER PHARMACEUTICALS INC. (JP) 2003-07-16 EP disclosed
EP-1326864-A2 ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS PFIZER PHARMACEUTICALS INC. (JP) 2003-07-16 EP disclosed
WO-2002032422-A2 EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS PFIZER PHARMACEUTICALS INC. (JP) 2002-04-25 WO disclosed
WO-2002032900-A2 ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS PFIZER PHARMACEUTICALS INC. (JP) 2002-04-25 WO disclosed